People · Operator
Named in public records as an officer, director or promoter · active 2010–2021 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Impel Neuropharma Inc | — | Other Health Care | Series B | $51.1M | $34.5M | 2010 |
John D. Hoekman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John D. Hoekman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mahendra D. Shah | 1 | 2 |
| Robert D. Mittendorff | 1 | 2 |
| Michael P. Hite | 1 | 1 |
| John D. Leaman | 1 | 1 |
| Aaron D. Royston | 1 | 1 |
| Ali D. Satvat | 1 | 1 |
| Adrian D. Adams | 1 | 1 |
| David D. Allison | 1 | 1 |
| Diane D. Wilfong | 1 | 1 |
| Tim D. Nelson | 1 | 1 |
| Jon D. Congleton | 1 | 1 |
| Stewart D. Parker | 1 | 1 |
| Jim D. Young | 1 | 1 |
| Rodney D. Ho | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.